Sight Sciences, Inc.2024财年实现净利润-51.51百万美元，同比增加7.27%

市场透视2025-03-10

3月10日，Sight Sciences, Inc.（SGHT.US）公布财报，公告显示公司2024财年净利润为-51.51百万美元，同比增加7.27%；其中营业收入为79.87百万美元，同比减少1.47%，每股基本收益为-1.03美元。从资产负债表来看，Sight Sciences, Inc.（SGHT.US）总负债55.32百万美元，其中短期债务533000.00美元，资产负债比为0.03，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2518811662?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-10 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2518811662","market":"us","top_or_hot":-1,"title":"Sight Sciences, Inc.2024财年实现净利润-51.51百万美元，同比增加7.27%","media":"市场透视","content":"<div>\n<p>3月10日，Sight Sciences, Inc.（SGHT.US）公布财报，公告显示公司2024财年净利润为-51.51百万美元，同比增加7.27%；其中营业收入为79.87百万美元，同比减少1.47%，每股基本收益为-1.03美元。从资产负债表来看，Sight Sciences, Inc.（SGHT.US）总负债55.32百万美元，其中短期债务533000.00美元，资产负债比为0.03，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000119abf17530&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sight Sciences, Inc.2024财年实现净利润-51.51百万美元，同比增加7.27%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSight Sciences, Inc.2024财年实现净利润-51.51百万美元，同比增加7.27%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-10 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000119abf17530&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3月10日，Sight Sciences, Inc.（SGHT.US）公布财报，公告显示公司2024财年净利润为-51.51百万美元，同比增加7.27%；其中营业收入为79.87百万美元，同比减少1.47%，每股基本收益为-1.03美元。从资产负债表来看，Sight Sciences, Inc.（SGHT.US）总负债55.32百万美元，其中短期债务533000.00美元，资产负债比为0.03，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000119abf17530&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGHT","symbol_name":"Sight Sciences, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000119abf17530&s=b","article_id":"2518811662","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000119abf17530&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2518811662","pubTimestamp":1741536054,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"3月10日，Sight Sciences, Inc.公布财报，公告显示公司2024财年净利润为-51.51百万美元，同比增加7.27%；其中营业收入为79.87百万美元，同比减少1.47%，每股基本收益为-1.03美元。从资产负债表来看，Sight Sciences, Inc.总负债55.32百万美元，其中短期债务533000.00美元，资产负债比为0.03，流动比率为0.10。机构评级：截至2025年3月10日，当前有6家机构对Sight Sciences, Inc.目标价做出预测，其中目标均价为3.50美元，其中最低目标价为2.50美元，最高目标价为5.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"SGHT":"Sight Sciences, Inc."},"translate_title":"Sight Sciences, Inc. achieved net profit of-US $51.51 million in fiscal year 2024, a year-on-year increase of 7.27%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGHT":1},"content_text":"3月10日，Sight Sciences, Inc.（SGHT.US）公布财报，公告显示公司2024财年净利润为-51.51百万美元，同比增加7.27%；其中营业收入为79.87百万美元，同比减少1.47%，每股基本收益为-1.03美元。从资产负债表来看，Sight Sciences, Inc.（SGHT.US）总负债55.32百万美元，其中短期债务533000.00美元，资产负债比为0.03，流动比率为0.10。机构评级：截至2025年3月10日，当前有6家机构对Sight Sciences, Inc.目标价做出预测，其中目标均价为3.50美元，其中最低目标价为2.50美元，最高目标价为5.00美元。公司简介：Sight Sciences Inc 是一家眼科医疗设备公司，专注于外科和非手术技术的开发和商业化，用于治疗普遍的眼病。其青光眼外科产品组合以 OMNI 手术系统为特色，该设备可以通过一个设备和一个角膜切口来降低成人原发性开角型青光眼患者的眼压，促进成形术和小梁切开术的执行。该公司的干眼症部门的产品组合包括眼科医生和验光师的TearCare 系统。它的主要收入来自青光眼手术的收入。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2518811662","isCrawlerRequest":true}